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Background: Research on physical activity and nutrition interventions aimed at positively impacting symptom
management, treatment-related recovery and quality of life has largely excluded head and neck (HN) cancer
populations. This translates into a lack of clinical programming available for these patient populations. HN cancer
patients deal with severe weight loss, with more than 70% attributed to lean muscle wasting, leading to extended
recovery times, decreased quality of life (QoL), and impaired physical functioning. To date, interventions to address
body composition issues have focused solely on diet, despite findings that nutritional therapy alone is insufficient
to mitigate changes. A combined physical activity and nutrition intervention, that also incorporates important
educational components known to positively impact behaviour change, is warranted for this population. Our pilot
work suggests that there is large patient demand and clinic support from the health care professionals for a
comprehensive program.
Methods/Design: Therefore, the purpose of the present study is to examine the impact and timing of a 12-week
PA and nutrition intervention (either during or following treatment) for HN cancer patients on body composition,
recovery, serum inflammatory markers and quality of life. In addition, we will examine the impact of a 12-week
maintenance program, delivered immediately following the intervention, on adherence, patient-reported outcomes
(i.e., management of both physical and psychosocial treatment-related symptoms and side-effects), as well as
return to work.
Discussion: This research will facilitate advancements in patient wellness, survivorship, and autonomy, and carve
the path for a physical-activity and wellness-education model that can be implemented in other cancer centers.
Trial registration: Current Controlled Trials NCT01681654
Keywords: Head/neck cancer, Exercise, Progressive strength training, Quality of life, Cancer, Randomized controlled
trial, Nutrition, Lifestyle interventionBackground
Head and neck (HN) cancers include cancers of the lip,
oral cavity, oropharynx, hypopharynx, tonsil, salivary
glands, nasopharynx, nose paranasal sinus, and middle ear
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reproduction in any medium, provided the or[2]. HN cancers account for approximately 3% of all can-
cers in the United States and are nearly twice as common
among men as they are among women [1]. In 2011, ap-
proximately 52,000 people in the United States were diag-
nosed with HN cancers and over 5000 in Canada, and the
5-year survival rate is currently at 57% [1,3]. Advances in
medical detection and interventions are helping to in-
crease 5-year overall cancer survival rates, leading to an
ever-growing number of cancer survivors [4]. Since the
long-lasting effects of the disease and treatments may im-
pact all survivors, the focus on survivorship care and pa-
tient outcomes is paramount [5].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Capozzi et al. BMC Cancer 2012, 12:446 Page 2 of 9
http://www.biomedcentral.com/1471-2407/12/446There is persuasive evidence to suggest that two life-
style behaviors, physical activity (PA) and nutrition are
necessary components in cancer survivorship program-
ming [6]. PA has been shown to enhance patient
functional capacity, physical functioning, and body com-
position, as well as facilitate the management of treat-
ment related symptoms and side-effects including
fatigue, and nausea [7-11]. Nutritional counseling has
been found to improve dietary intake in patients who
face increased risk of malnutrition, thereby improving
outcomes and timely healing [12,13]. It is well estab-
lished that PA and nutrition interventions also promote
improved quality of life (QoL) in cancer survivors,
regardless of tumour site. To date, the vast majority of
lifestyle interventions have focused their attention on
breast cancer [12,14-16]. This has left other cancer
populations drastically underserved, including HN
cancer survivors, who are at significant risk of long-term
disability [17].
While HN cancer patients face issues similar to other
cancer survivor populations (i.e., fatigue, distress, physical
functioning), these populations also experience further
physical and psychological burden into survivorship,
affecting overall QoL status, rehabilitation, and return to
work [17-21]. HN cancer patients deal with severe weight
loss, with upwards of 70% attributed to lean muscle wast-
ing, leading to decreased physical functioning with regards
to locomotion, strength and respiration after treatment
[19,22]. This cancer-related skeletal muscle wasting, or
cachexia, exists due to imbalances between muscle protein
synthesis and degradation, and is unique from starvation
in the sense that it cannot be reversed or treated
solely with nutritional supplementation [23]. Cachexia
is defined as an unintentional weight loss of at least
5% premorbid weight occurring over 3 to 6 months
and will be the main cause of death for 20-40% of
HN cancer patients, a group especially challenged with
this syndrome [23,24].
Current interventions are largely focused on nutrition,
despite findings indicating that decreased food intake is
probably not directly related to this muscle wasting, and
that dietary intervention alone may increase fat mass
without affecting muscle tissue [25]. Couch et al. (2007)
also reported that although nutritional therapy is neces-
sary, alone it might be insufficient, prompting additional
or complementary treatment options [24]. At present
there is a lack of complementary treatment options to
help sustain or rebuild this wasted muscle, yet since
cachexia is a muscle wasting disease, interventions
targeted at increasing protein anabolism and decreasing
catabolism are warranted [26]. Strength training and
exercise hold great potential due to the associated
increases in lean muscle mass and improvements in
body composition, which have been seen in other cancerpopulations [8,27]. Currently, there are very few clinical
trials that examine the impact of strength training in
combination with a nutritional intervention for cachexia.
Besides the negative impact on overall health and sur-
vival, this muscle wasting syndrome is associated with
substantial mental and emotional fatigue, and signifi-
cantly decreased QoL, particularly in scores of emo-
tional, physical and social functioning categories
[18,23,24,28,29]. Exercise and diet have been found to
enhance QoL in HN survivors and help manage fatigue,
but the specific benefits of a lifestyle intervention during
treatment has yet to be investigated, and the question
pertaining to the appropriate time of intervention, dur-
ing treatment or following treatment, has yet to be
answered [17,30].
The purpose of this proposed research is to examine
the immediate and long term physical and psychosocial
benefits of a clinic-supported physical activity and nutri-
tion program during and after treatment for HN cancer
survivors, and to investigate the clinical implications
associated with increasing the promotion of healthy life-
style behaviors for this population. This research will
address the pressing need for clinic-supported HN can-
cer lifestyle interventions that effectively demonstrate
physical and psychosocial patient benefit.
Specifically, this study is designed to examine the
potential benefits of a lifestyle (PA, nutrition, and health
education) intervention. Specific objectives include the
following:
1. Whether a lifestyle intervention will improve
outcomes, including physiological (muscle mass
maintenance), fitness, psychological (QoL and
depression), smoking status, inflammatory markers,
and functional (return to work).
2. Whether it is optimal, in terms of outcomes, to
deliver the program during or after treatment
completion.
3. Whether a survivorship care plan (SCP) maintenance
program improves long-term healthy lifestyle
adherence.
Without exploration into these questions, HN cancer care
will continue to only partially serve patients in their quest
towards healthy cancer recovery, strong physical functioning
ability, improved QoL, and timely return to work. These
studies will provide concrete evidence for a clinic-supported
lifestyle intervention and maintenance program as a means
to mediate these currently unaddressed factors and improve
functioning and psychosocial outcomes.
The study hypotheses directly reflect the aims. It is
hypothesized that patients who are randomized to the
12-week lifestyle intervention at treatment start will
experience improved symptom management throughout
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evaluated by: a) decreased loss of lean body mass,
improved physical functioning and fitness outcomes,
improved Karnofsky Performance scores and decreased
levels of serum inflammatory markers b) improved patient
sense of wellbeing and feelings of control and there-
fore overall reported QoL. It is also hypothesized that
patients who are randomized to the 12-week lifestyle
intervention at treatment start (immediate intervention)
will experience improved symptom management following
treatment compared to delayed intervention patients who
begin the 12-week intervention following treatment.
Improved symptom management will be evaluated follow-
ing intervention by: a) decreased loss of lean body mass,
improved physical functioning and fitness outcomes,
improved Karnofsky Performance scores and decreased
levels of serum inflammatory markers as well as the asso-
ciated b) improvement in patient sense of wellbeing, feel-
ings of control, and overall reported QoL score.
Methods/Design
Study design
This study will be a randomized controlled trial, with an
Immediate Lifestyle Intervention (ILI) group and a Delayed
Lifestyle Intervention (DLI) group. The DLI group will act
as the control group during the first 12-week phase. Flow
through the study is portrayed in Figure 1. Research ethics
approval to conduct this study was obtained through the
Conjoint Health Research Ethics Board of the Faculties of
Medicine, Nursing and Kinesiology, at the University of
Calgary (Ethics ID: E-24446).
Treatment arms
Once enrolled, the participant will be randomized to
either begin the intervention at the time of treatment ini-
tiation (ILI, n = 40), or to begin the intervention following
treatment completion (DLI, n = 40). Patients will be
recruited, cleared for participation, receive an initial as-
sessment, and then be randomized into either the ILI
group or the DLI group. Participants in the ILI group will
receive an individualized exercise and dietary program
based on their exercise assessment and dual energy x-ray
absorptiometry (DXA) scan results, will attend twice
weekly group exercise classes, and perform their indivi-
dualized at-home program an additional two times per
week. In addition, participants will be required to
attend six education sessions during the 12-week inter-
vention. The DLI group will receive this intervention
upon their treatment completion, at approximately 12-
weeks post-randomization.
Physical activity intervention
Participants will attend twice weekly exercise classes, for
12 weeks, at the Thrive Centre or Tom Baker CancerCentre Holy Cross location to practice their program in
a supported group-based environment. In addition, par-
ticipants will receive equipment to perform the program
at least two days per week at home. The focus of the PA
program will be progressive strength training, helping to
rebuild lost muscle mass and prevent further protein
degradation. Participants will be asked to perform 8-10
prescribed low-intensity exercises four times per week,
conducting approximately 2 sets of 8-10 repetitions.
During this time, participants will be asked to record
daily activity in a PA log.
Dietary intervention
Patients will be screened weekly using the Patient
Generated-Subjective Global Assessment tool (PG-SGA)
during treatment and will complete a 3-day dietary rec-
ord at baseline, four weeks, eight weeks, and then
at each assessment point thereafter [31,32]. This infor-
mation will be scored and a dietitian will review and
provide appropriate feedback at weekly dietary counsel-
ing sessions.
Educational intervention
The educational seminars will focus on providing both
nutrition and PA information that will aid in the prepar-
ation for behavior change. Specifically, weekly education
classes addressing the impact of lifestyle choices on
treatment-related symptoms and outcomes, teaching
behavior change techniques (goal setting, journaling
etc.), and providing time for supportive discussion will
be held immediately after an exercise session one time/
week.
Maintenance intervention
Following the initial intervention, participants in both
the immediate and delayed intervention arms will be
randomized (20:20 in each group) to either a control (no
maintenance program other than access to the workout
center) or a 12-week maintenance program immediately
following the intervention, consisting of an SCP with
both exercise and dietary prescriptions, weekly group-
based PA classes, and ongoing monthly education
classes.
Study population
The intervention participants will consist of HN
patients who have been newly diagnosed and who
have not yet started treatment. Patients will be eli-
gible to participate if they: 1) are over 18 years of
age 2) have received a diagnosis of nasopharyngeal,
oropharyngeal or hypopharygeal cancer, 3) are sched-
uled to receive radiation treatment, 4) are able to walk
without assistance, 5) have received clearance for exer-
cise from their treating oncologist, 6) live in the Calgary
Patient:
1. Diagnosed of nasopharyngeal,  
oropharyngeal or hypopharygeal cancer,
2. Will be receiving radiation therapy,
3. Lives in Calgary area, is over 18 yrs, able to 
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Figure 1 Study design protocol.
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ested in participating in the program. Reasons for exclu-
sion will be documented as feasibility outcomes of the
trial.
Recruitment
Participants will be recruited through the HN clinic
at the Tom Baker Cancer Centre, with direct referral
and clearance for exercise from a physician. Once theparticipant is referred, they will be contacted to discuss the
study details and, if interested and meet the inclusion cri-
teria, will receive an appointment time for an initial assess-
ment. At this time, participants will complete a written,
informed consent before participation in the study.
Measures
The assessments will consist of a battery of patient-
reported instruments to assess demographics, medical
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smoking status as well as a physical fitness assessment
and a comprehensive body composition assessment.
Inflammatory markers, including TNF, IL-6, IL-1, IL-8
and C-reactive protein will be assessed in serum. A
chart review will also be conducted to assess diagnosis,
treatment plan and outcomes. The assessment will take
approximately 1.5 hours to complete and will occur
at baseline (time of diagnosis), 3, 6, 9, and 12-months
post diagnosis.
Health and lifestyle questionnaires
Demographics
Demographics will be collected by self-report including
gender, age, ethnicity, marital status, education, employ-
ment status, return to work status and annual income.
Medical variables, abstracted from chart reviews by
study staff, will include specific diagnosis (type, stage,
initial or recurrence), time since diagnosis, and current
treatment.
Physical activity behaviour
PA will be assessed using Godin’s leisure score index
(LSI) of the GLTEQ (Godin Leisure Time Exercise
Questionnaire) [33]. The LSI is a 3-item measure
assessing the frequency and duration of mild, moder-
ate and strenuous bouts of exercise performed dur-
ing free time in a typical week. In this study,
participants will be asked to recall their exercise
levels over the past month. The LSI has been suc-
cessfully used with adult cancer patients and survi-
vors, and has good reliability and validity as
indicated by an independent evaluation to nine other
self-report measures of exercise [34-36].
Patient-reported outcomes
Quality of life
QoL will be assessed using the Functional Assessment of
Cancer Therapy- Anemia module (FACT-AN), and the
NCCN-FACT Fact Head/Neck Symptom Index-22
(FHNSI-22). These tools examine the 5 major subsets of
well-being for cancer survivors, including physical well-
being, social/family well-being, emotional well-being,
functional well-being, and additional concerns specific
to HN cancer survivors. Based on these scales, the Trial
Outcome Index (TOI) will be calculated, providing a
final score based on the sum of the subscales.
Depression
Depression will be assessed using the Center for Epi-
demiological Studies on Depression Scale (CES-D). This
20-item questionnaire screens for self-reported depres-
sive symptoms [37]. It has shown excellent internal
consistency in the cancer population with perfectsensitivity and strong specificity in a study of 33 cancer
patients [38].
Smoking history
Smoking history will be assessed by a self-report ques-
tionnaire. This questionnaire will classify patients as
non-smokers, former smokers and current smokers.
Weekly PA logs
Participants will complete daily PA logs. These logs will
highlight daily activities, the intensity of those activities
(1-10 Rated Perceived Exertion Scale), and the duration
of those activities.
Biweekly Edmonton symptom assessment system (ESAS)
Participants will complete the ESAS bi-weekly, before
and after class. The ESAS is a valid and reliable assess-
ment tool to evaluate the nine more common symptoms
experienced by cancer patients [39].
Diet behaviour
Diet will be assessed using a 3-day Diet Record once
per month, and the PG-SGA will be completed once
per week. The 3-Day Diet Record is said to be the
most accurate for mean macronutrient content and
appropriate for use in studies where subjects may
consume a wide variety of foods [40,41]. Participants
are instructed to record their daily consumption, in-
cluding alcohol intake, over a period of three days,
one of which must be a weekend day. Written
instructions and a sample entry are provided to in-
crease accuracy of the daily record. The PG-SGA as-
sessment tool has been show to improve treatment
outcomes, decrease side-effects, and improve weight-
management in cancer patients, and therefore will be




Standing height and weight will be measured on a Heath
Carter balance beam scale. Participants will be weighed
weekly during active treatment and during the lifestyle
intervention and maintenance phase. Weight will also be
tracked at each of the 5 assessments. Waist circumfer-
ence will be measured with an anthropometric tape
measure at the top of the iliac crest and hip circumfer-
ence will be measured at the greatest girth of the gluteus
with the participant standing erect [42]. Waist to hip
ratio and body mass index (kg ×m-2) will be calculated
[43]. A DXA scan (Hologic QDR 4500; Hologic Inc, Bed-
ford, MA) will be performed a total of five times, at each
assessment. Hologic QDR software will be used to deter-
mine lean mass, fat mass and bone mineral density.
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Laboratory at the University of Calgary.Cardiorespiratory fitness
Although aerobic fitness is not the specific focus of the
exercise intervention, the resistance training may likely
have ancillary impact on cardiorespiratory fitness. While
a submaximal cardiorespiratory test would be the stand-
ard, due to the limitations in this patient population, a
functional measure of aerobic fitness was deemed to
have greater value, as well as be more reflective of the
training focus in the intervention. Resting heart rate will
be measured using a heart rate monitor (Polar) and rest-
ing blood pressure (mmHg) will be measured in dupli-
cate on the left arm using a sphygmomanometer and
stethoscope using standardized procedures [43]. Rating
of perceived exertion (Borg scale) will be completed
immediately prior to and immediately after completion
of the functional aerobic capacity test. The six-minute
walk test (6MWT) will be used to assess changes in
functional aerobic capacity. Using the standardized
protocol, participants will be asked to walk as far as they
can around a 400-meter track for six minutes [43]. The
point reached at 6 minutes will be marked and measured
to the nearest 0.5 meter. Post-exercise HR and BP will
be measured one minute after a standard cool-down and
after sitting quietly for five minutes before dismissal
from the fitness-testing laboratory.Musculoskeletal fitness
Muscular strength will be assessed using a combined
grip strength of the right and left hands using a hand
dynamometer. A sum will be determined in kilograms
from the best score of 2 trials recorded for each hand
according to the CPAFLA protocol [43]. Lower body
strength will be assessed using a 30-second sit to stand
test. The number of times participants can stand from a
seated position in 30-second will be examined [44].Flexibility
Flexibility will be assessed by a trunk forward flexion
sit-and-reach test using a Wells-Dillon flexometer. The
test will follow a standard protocol, with two trials
allowed and the highest score to the nearest 0.5 cm
recorded [43].Balance
Balance will be assessed using a static balance test. The
test requires the participant to balance on one foot and
then the other as long as they can (length of time) while
standing on a 2.54 by 2.54 by 30.5 cm base using a stan-
dardized protocol, reported by Fleishman [45].Measures of physical functioning
Participant performance score
The Karnofsky Performance Score (KPS) will be used to
measure the participant’s general ability to accomplish
tasks of daily-living and overall well-being. The Score is
used to reflect the patient’s performance or function and
ability to work, and is practical, objective, and has been
validated and used for the past 50 years [46].
Blood data collection
Inflammatory markers
Inflammatory factors will be evaluated as they are asso-
ciated with cancer cachexia and muscle wasting and may
be modified by exercise [47,48]. An overnight fasted
blood draw will be collected at baseline, 3 months post
diagnosis, 6 months post diagnosis, 9 months post diagno-
sis, and 12 months post diagnosis. Once further funding is
secured, serum inflammatory cytokine concentrations will
be assessed in-house (Dr. Raylene Reimer’s laboratory)
according to our established protocols. TNF, IL-6, IL-1,
IL-8 and C-reactive protein will be quantified using Milli-
plex Human Cytokine kits (Millipore, Billerica, MA). Plate
reading will be provided as a fee-for service through Eve
Technologies Inc. (Calgary, AB).
Sample size calculation
Sample size calculations are based on minimum partici-
pants required for a linear mixed models analysis as
derived from Schmitz et al. [27]. They suggest a strong
relationship between strength training and improve-
ments in lean tissue in cancer patients. The power calcu-
lation was derived using G-Power [49,50]. The effect size
of 0.63 was calculated based on relevant literature asso-
ciated with similar interventions and α= 0.05 and
β= 0.80 were used [22,27]. Based on these numbers, it
was determined that a power of n = 32 is required for
each group. Accounting for potential participant drop-
out, a 20% buffer will be added and a total of n = 40 for
each group, for a total n = 80. All intervention partici-
pants will be recruited for the intervention over year
one of the study. Preliminary data from the EHNANCE
exercise program for HN patients indicates that this re-
cruitment goal is feasible (36 patients recruited in 4
months, with adherence at 90%).
Analysis
Analyses will include feasibility (participants recruited;
program attendance), descriptive analyses and statistical
tests examining change over the program duration. The
raw data will be analyzed using SPSS Version 19.0, and
will primarily consist of linear mixed models. Informa-
tion from the 3-Day Diet Records will be analyzed with
Diet Analysis Plus 10.0 software (Wadsworth Inc.) to
generate total daily energy intake, macronutrient and
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data will be analyzed using SPSS.
For the primary objective, we will be utilizing linear
mixed models analyses, to examine change between
groups and over time, with the primary outcome being
body composition changes over time and between the two
groups (immediate intervention and delayed intervention).
For the secondary objective, we will also examine
change over time in health related fitness, QoL, func-
tional status (Karnofsky), dietary intake, and markers of
inflammation.
Protection against bias
To protect against bias, participants will be randomly
assigned to one of the two intervention arms, using
randomization.com, a web-based random number gener-
ation program with a 1:1 allocation ratio. Exercise testers
who will be evaluating participant fitness measures will
be blinded to participant allocation. When participants
are recruited, they will be told that there is an equal pos-
sibility that they will be assigned to one of the two
groups (immediate lifestyle intervention or the delayed
lifestyle intervention group) and that the impact of inter-
vention timing is not yet known. Once they have com-
pleted their initial assessment, they will be contacted by
the research coordinator and told which group they have
been allocated and receive an explanation of the proto-
col and their responsibilities.
Discussion
HN cancer survivors are at an increased risk for
physical and psychological burden into survivorship,
with many complications related to weight loss and
muscle wasting [19,22]. This has direct implications
on patient QoL, rehabilitation, and return to work
[17-21]. The proposed study will provide a wide-
ranging investigation into the impact of PA, diet
screening and education on body composition before
and following treatments. This work will specifically
address whether a lifestyle approach can help to pre-
serve muscle mass and whether there is a link be-
tween body composition and patient reported
outcomes, such as QoL. The goal of this research is
to address a current unmet need and respond dir-
ectly to patient demand for comprehensive, patient-
centered care by delivering an intervention combin-
ing PA, nutritional and educational elements. This
intervention will target physical and psychosocial
well-being, promoting improved management of
patients’ physical and psychosocial responses to treat-
ment as well as improving long-term outcomes. Fur-
ther, this research will evaluate the comparative
effectiveness of a comprehensive PA, nutrition and
education intervention at different points along thecancer care trajectory, to identify the most effective
clinical intervention point in patient care based on
rigorously assessed health outcomes. The evidence
required for successful clinical adoption and integra-
tion of this multidisciplinary clinic-based intervention
will be gathered and a model will be built for future
program translation. In addition, and crucial to the
success of this clinic-based program, an opportunity
for advanced collaboration among health care provi-
ders will be supported, ultimately enhancing the pa-
tient care experience and resulting in improved vital
health outcomes.
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